DM
Insider buying
Daniel M Schmitt bought $50K of ACTU stock
Daniel M Schmitt, President, CEO and Director of Actuate Therapeutics, Inc. (ACTU), bought 140,844 shares of ACTU stock worth $50K, per an SEC Form 4 filed Oct 29, 2026.
The shares came through a private deal, not the open market.
The trade happened on Oct 28, 2026, 1 day before it was made public.
ACTU has moved -3.2% since the trade date, from $0.38 to $0.37 (Oct 29, 2026 close).
- Traded
- Oct 28, 2026
- Disclosed
- Oct 29, 2026
- Filing delay
- 1 day
- Price since
- -3.2%
- Role
- President, CEO and Director
- Source
- SEC Form 4
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.